Here, we demonstrate that high levels of AMPKα1 are correlated with a poor prognosis in CRC patients and inhibition of AMPKα1 profoundly kills CRC cells by attenuating glutathione metabolism. This evidence concerns the gene PRKAA1 and colorectal carcinoma.